Genetics and genomics in medicine
Genetics and genomics in medicine focus on analyzing and using genetic data to diagnose, treat and prevent diseases. The continued study of gene functions and interactions in health and disease informs emerging approaches to personalized medicine and population health management strategies for chronic, rare and novel diseases.
Top Stories
-
Feature
04 Nov 2024
AMPEL develops a blood test for cardiovascular disease
Amrie Grammer, AMPEL's co-founder, president, and chief scientific officer of AMPEL BioSolutions, explains the company's CardioGENE blood test for cardiovascular disease risk. Continue Reading
-
Feature
28 Oct 2024
Addressing gene and cell therapy commercialization challenges
InspiroGene addresses some gene and cell therapy commercialization challenges by offering logistics programs, distribution services, a biologics specialty pharmacy and a patient hub. Continue Reading
-
News
11 Apr 2022
Researchers Identify 42 New Genes for Alzheimer's Disease
The study found that a specific biological signaling pathway involving TNF-alpha is implicated in Alzheimer's disease and could damage the brain cells. Continue Reading
-
News
05 Apr 2022
Scientists Publish Comprehensive ‘Gapless’ Human Genome
The first full ‘gapless’ human genome will become a reference guide to genetic variations seen in human beings and allows experts to explore new territories in precision medicine. Continue Reading
-
News
28 Mar 2022
Mount Sinai Develops CRISPR Technology to Advance Cancer Treatment
The CRISPR technology, Perturb-map, uses a genetic barcode to mark cancer cells with different gene modifications and image the cancer cells and neighboring cancer cells within the tissue. Continue Reading
-
News
22 Mar 2022
BioMarin Pharmaceutical's Gene Therapy Helps Hemophilia A Patients
BioMarin's gene therapy decreased annualized factor VII concentrate use and mean treated bleeding rates post-infusion by 99% and 84%, respectively, in patients with severe hemophilia A. Continue Reading
-
News
21 Mar 2022
Thermo Fisher Introduces System to Enable Cell Therapy Development
Providers can leverage the system to overcome manufacturing challenges that hinder cell therapy production, bringing life-saving therapies to patients faster. Continue Reading
-
Feature
16 Mar 2022
CRISPR Genome-Editing Technology: The Future of Gene Editing
CRISPR genome-editing technology has revolutionized genetic engineering by introducing the ability to alter an organism’s DNA to precision medicine. Continue Reading
-
News
24 Nov 2021
Gilead Boosts Oncology Pipeline With 3 Clinical-Stage Programs
Gilead exercised its options to three programs in Arcus Biosciences’ clinical-stage portfolio, including anti-TIGIT molecules and a dual adenosine A2a/A2b receptor antagonist. Continue Reading
-
News
16 Nov 2021
Pfizer, Biohaven Commercialize Generic Drug For Migraine Attacks
Biohaven will remain responsible for further development of Rimegepant, while Pfizer will gain rights outside of the US to zavegepant, a CGRP receptor being studied to treat migraines. Continue Reading
-
News
26 Oct 2021
Boehringer, Partners Boost Gene Therapy Development For CF
The partnership will advance gene therapy BI 3720931, a novel, replication-deficient lentiviral vector that introduces a healthy CFTR gene into the relevant target cells of individuals with CF. Continue Reading
-
News
05 Oct 2021
Thermo Fisher Launches Medium to Support Cell, Gene Therapy
The Gibco CTS NK-Xpander Medium is the first medium to support the expansion of NK cells for cell and gene therapy applications. Continue Reading
-
News
28 Sep 2021
bluebird bio Submits BLA for Gene Therapy to Treat β-thalassemia
bluebird bio based its BLA submission for the gene therapy on data from four Phase 3 clinical trials, which found that 89% of patients across all ages achieved transfusion dependence. Continue Reading
-
News
21 Sep 2021
Thermo Fisher Launches System to Scale Gene Therapy Workflows
The AAV-MAX system aims to simplify AAV vector production workflow, increase productivity, and boost cost efficiency to enable scalable gene therapy workflows. Continue Reading
-
News
15 Sep 2021
FDA Clears IND for Neurogene’s Gene Therapy for Batten Disease
With FDA clearance, Neurogene will initiate a Phase 1/2 trial of its gene therapy, NGN-101, to assess its safety, tolerability, and efficacy in patients with Batten disease. Continue Reading
-
News
09 Sep 2021
FDA Halts BioMarin’s Trial Assessing Gene Therapy in Rare Disease
FDA based its decision on safety findings from a pre-clinical, non-GLP pharmacology study, which assessed the durability of the gene therapy in mice bearing two germline mutations. Continue Reading
-
News
07 Sep 2021
NeuExcell, Spark Therapeutics to Develop Gene Therapy for HD
Spark Therapeutics will receive access to NeuExcell’s neuroregenerative gene therapy platform and capabilities to advance treatment options for Huntington’s Disease. Continue Reading
-
News
09 Jun 2021
Biden Pushes Policy Changes to Protect Pharmaceutical Supply Chain
The Biden Administration is pushing Congress to focus on two priority objectives and six recommendations to address the reliability of US pharmaceutical supply chains. Continue Reading
-
News
06 May 2021
CVS Caremark Prescription Drug Trend Rose to 2.9% in 2020
COVID-19 and social injustices in 2020 also increased the need to keep prescription drug spend in check and create equitable access to high-quality services for every American. Continue Reading
-
News
03 May 2021
Northwell, Pear Therapeutics Provide New Opioid Treatment Options
Opioid and substance-use disorder patients will have access to an innovative FDA-authorized treatment option, called prescription digital therapeutics, from Northwell Health and Pear Therapeutics. Continue Reading
-
News
27 Apr 2021
Health2047 to Improve Clinical Trial Access with New Venture
The innovation arm of the AMA recently announced the spinout of a new company, SiteBridge Research, that aims to improve clinical trial access among small practices. Continue Reading
-
News
12 Mar 2021
CVS Works to Improve Drug Affordability, Accessibility
CVS Caremark manages medications for a wide range of clients, putting them in an ideal position to address drug affordability and accessibility. Continue Reading
-
News
11 Mar 2021
GE Gets $41M to Accelerate Vaccine Manufacturing, Distribution
The five-year $41M award from DARPA will increase the speed of nucleic acid-based vaccine manufacturing and distribution to get treatments to individuals in need. Continue Reading
-
News
10 Mar 2021
US Buys More Doses of Eli Lilly’s COVID-19 Antibody Therapy
The additional doses of the COVID-19 antibody therapy combination will be allocated together through the end of March 2021. Continue Reading
-
News
10 Mar 2021
Merck to Manufacture Johnson & Johnson COVID-19 Vaccine for US
The historic collaboration will advance the manufacturing of Johnson & Johnson’s COVID-19 vaccine drug substance and fill-finish capacity in order to accelerate vaccination efforts in the US. Continue Reading
-
News
09 Mar 2021
AstraZeneca Furthers COVID-19 Vaccine Rollout Through COVAX
The first COVID-19 vaccine shipments were brought to Ghana and Cote D’Ivoire and more will begin arriving this week in the Philippines, Indonesia, Fiji, Mongolia, and Moldova. Continue Reading
-
News
03 Mar 2021
Eli Lilly to Codevelop Inhibitors for Neurodegenerative Diseases
The company will help codevelop and commercialize Rigel Pharmaceutical’s RIPK1 inhibitor for immunological and neurodegenerative diseases. Continue Reading
-
News
24 Feb 2021
GSK, VIR Expand Agreement to Develop Novel Therapies for Influenza
The expanded agreement gives GSK exclusive rights to collaborate with Vir Biotechnology on the development of potential novel therapies for various diseases. Continue Reading
-
News
23 Feb 2021
HHS, DoD Buy 100M More Doses of Moderna, Pfizer COVID-19 Vaccines
The US government’s additional purchase of Moderna and Pfizer’s respective COVID-19 vaccines brings its total vaccine order to 600 million doses. Continue Reading
-
News
22 Feb 2021
Speeding Innovation in Genomics with Modern-Day Infrastructure
Next-generation sequencing is critical to the use of genomics to improve clinical diagnostics and therapeutics for a wide range of diseases, from coronavirus to cancer. Continue Reading
-
News
18 Feb 2021
GoodRx Reports Largest Uptick in Prescription Drug Prices in Years
Prescription drug prices increased for over 800 medications in January 2020by an average of 4.6%, GoodRx reported. Continue Reading
-
News
17 Feb 2021
AstraZeneca, Biologika to Increase Output of COVID-19 Vaccine
The companies will boost manufacturing and supply capacity of AstraZeneca’s COVID-19 vaccine, as well as build a large additional drug substance capacity for the future. Continue Reading
-
News
17 Feb 2021
Eli Lilly Enhances Local Access to COVID-19 Antibody Therapies
Eli Lilly will work with local health centers to launch dedicated infusion center locations in Indiana and provide individuals access to COVID-19 antibody therapies. Continue Reading
-
News
16 Feb 2021
Pfizer Boosts Access to Cancer Treatments in Developing Countries
Pfizer and the IDA Foundation will provide millions of more patients across Latin America, Asia, Africa, and the Western Pacific region with the opportunity to access cancer treatments. Continue Reading
-
News
15 Feb 2021
Pharmaceutical Supply Chain Increases Outpatient Drug Costs
A PhRMA report found that the cost of provider-administered medicines is inflated by various entities in the pharmaceutical supply chain, affecting health plans, employees, and patients alike. Continue Reading
-
News
12 Feb 2021
CVS Health Boosts Access to COVID-19 Vaccines Across 11 States
The pharmacy has secured 250,000 initial doses for eligible populations in certain states in a bid to expand access to COVID-19 vaccines. Continue Reading
-
News
09 Feb 2021
GSK, CureVac to Develop Next Generation mRNA COVID-19 Vaccines
The companies are partnering to develop additional mRNA COVID-19 vaccines that address multiple variants of the disease, including possible strains in the future. Continue Reading
-
News
04 Feb 2021
Top Pharma Companies Boost Access to Drug Development Pipeline
Top pharma companies, including Novartis, GSK, and Johnson & Johnson, advance product planning to ensure access to drug development pipelines in low-income countries. Continue Reading
-
News
03 Feb 2021
US Prescription Drug Prices 256% Higher Than Other Countries
Specifically, US prescription drug prices were 218% of prices in Canada, 170%of prices in Mexico, 779% of prices in Turkey, and 209%of prices in Japan. Continue Reading
-
News
02 Feb 2021
COVAX Purchases 40M Doses of Pfizer, BioNTech’s COVID-19 Vaccine
The first doses of the COVID-19 vaccine will be delivered this year, with Pfizer and BioNTech also providing its candidate to 92 lower and lower-middle-income countries at a non-for-profit price. Continue Reading
-
News
27 Jan 2021
FDA Authorizes First Long-Acting Injectable for HIV Treatment
The agency authorized ViiV Healthcare’s HIV treatment,Cabenuva, to be administered in adults once a month and replaces the current antiretroviral regimen. Continue Reading
-
News
20 Jan 2021
Eli Lilly, Merus to Develop T-Cell Bispecific Antibody Therapies
The collaboration will leverage Merus’ Biclonics platform and Loxo Oncology’s scientific drug design to research and develop three T-cell bispecific antibody therapies. Continue Reading
-
News
19 Jan 2021
Switzerland Authorizes Moderna’s mRNA COVID-19 Vaccine
The authorization of Moderna’s mRNA COVID-19 vaccine comes a month after the Swiss Federal Government secured 7.5M doses. Continue Reading
-
News
14 Jan 2021
HHS Buys 1.25M More Doses of Regeneron’s COVID-19 Antibody Cocktail
The additional supply of the COVID-19 antibody cocktail will be used in a total of 300,000 non-hospitalized coronavirus patients at no cost as part of Operation Warp Speed. Continue Reading
-
News
08 Jan 2021
Kite, Oxford BioTherapeutics Partner to Research Cell Therapies
The subsidiary of Gilead and Oxford BioTherapeutics will use a discovery platform to generate antibodies for cell therapies focused on hematologic and solid tumor indications. Continue Reading
-
News
07 Jan 2021
Fujifilm to Invest $40M in Viral Vector Manufacturing Facility
The viral vector manufacturing facility will boost Fujifilm’s presence in Massachusetts within the academia and pharma communities and perform important research in advanced therapies. Continue Reading
-
News
06 Jan 2021
FDA Approves First Generic Drug for Severe Hypoglycemia
The agency approved the generic drug from Amphastar Pharmaceutical for use in diabetics with severe hypoglycemia and as a diagnostic aid in radiographic exams of the stomach and bowel. Continue Reading
-
News
05 Jan 2021
Moderna Ups COVID-19 Vaccine Manufacturing Estimate to 600M in 2021
Moderna increased its COVID-19 vaccine manufacturing estimate from 500M to 600M doses of mRNA-1273 for 2021. Continue Reading
-
News
04 Jan 2021
EU to Acquire Extra 100M Doses of Pfizer’s COVID-19 Vaccine
The EU will now acquire a total of 300 million doses of Pfizer and BioNTech’s mRNA COVID-19 vaccine, which is expected to be delivered to all member states by the end of 2021. Continue Reading
-
News
28 Dec 2020
Thermo Fisher Breaks Ground on Plasmid DNA Manufacturing Facility
The plasmid DNA manufacturing facility will expand on the company’s efforts to develop and manufacture gene and cell therapies. Continue Reading
-
News
21 Dec 2020
US Buys Extra 100M Doses of Moderna’s COVID-19 Vaccine
Moderna’s COVID-19 vaccine candidate, mRNA-1273, will be shipped immediately following emergency use authorization from FDA. Continue Reading
-
News
16 Dec 2020
Treameau Looks to Bring Back Vioxx for Non-Opioid Pain Relief
With a grant, the pharmaceutical company is developing rofecoxib, which recalled decades ago, as a non-opioid pain treatment for patients with hemophilic arthropathy. Continue Reading
-
News
16 Dec 2020
Canada Opts to Double Doses of Moderna’s COVID-19 Vaccine
The Canadian government initially signed on for 20 million doses of Moderna’s mRNA-based COVID-19 vaccine, but doubled its order as an approval draws near. Continue Reading
-
News
09 Dec 2020
Bayer Launches Cell, Gene Therapy Platform for Pharma Innovation
The cell and gene therapy platform addresses the gap in global demand for development and manufacturing of gene therapies, according to Bayer. Continue Reading
-
News
08 Dec 2020
AbbVie, Frontier Medicines Partner to Develop Novel Drug Therapies
The multi-year, multi-program research and development partnership will deliver innovative novel drug therapies to patients across the cancer and immunological disease space. Continue Reading
-
News
07 Dec 2020
US Govt Purchases Additional 650,000 Doses of COVID-19 Antibody
The additional purchase of Eli Lilly & Company’s COVID-19 antibody, LY-CoV555, brings the total doses purchased by the US government to 950,000. Continue Reading
-
News
02 Dec 2020
HHS to Allocate Doses of Regeneron’s COVID-19 Antibody Therapy
Weekly allocations of the COVID-19 antibody therapy to state and territorial health departments will begin immediately based on confirmed cases over the previous 7 days, HHS said. Continue Reading
-
News
01 Dec 2020
Rare Disease Drug from Alnylam Gets FDA Approval
The FDA approval means providers can use the rare disease drug Oxlumo in pediatric and adult patients with primary hyperoxaluria type 1, which causes recurrent kidney stones and loss of kidney function. Continue Reading
-
News
30 Nov 2020
Eli Lilly, Precision to Research Gene Therapies for Genetic Disorders
The research collaboration will initially focus on developing gene therapies for three lead targets with the right to select three additional gene targets. Continue Reading
-
News
30 Nov 2020
Considerations for Value-Based Drug Pricing During COVID-19
A new analysis describes 3 approaches to value-based drug pricing that address prices, access to treatments, and pharmaceutical company profitability. Continue Reading
-
News
18 Nov 2020
COVID-19 Drug Discovery for Early Treatment Lacking, But Needed
COVID-19 drug discovery efforts have largely focused on hospitalized patients, but de novo drug design for early treatment of the virus could mitigate the impact of future outbreaks, says Fauci. Continue Reading
-
News
18 Nov 2020
Amazon Launches Its Own Pharmacy, Prescription Delivery Service
The online pharmacy allows consumers to purchase medications and leverage a prescription delivery service that has free 2-day delivery for Prime members. Continue Reading
-
News
16 Nov 2020
Overcoming the Challenges of Distributing COVID-19 Antibody Drugs
The FDA’s recent approval of the emergency use of certain COVID-19 antibody drugs is a key step, but, but experts must address issues with approval, access, and distribution in hospitals and other care settings. Continue Reading
-
Answer
13 Nov 2020
Automating Adherence Packaging Improves Medication Management
Masonic Villages is leveraging adherence packaging automation to fill more prescriptions for its long-term care patients and boost medication management. Continue Reading
-
News
12 Nov 2020
Boston Children’s Gets $65M for Drug Discovery Innovation
The hospital received the funds from Deerfield Management Company to boost drug discovery and development and translate those early stage discoveries to novel therapies. Continue Reading
-
News
11 Nov 2020
HHS Buys 300K Doses of Eli Lilly’s COVID-19 Antibody Treatment
After receiving FDA emergency use authorization, HHS will now allocate nearly 300,000 doses of Eli Lilly’s COVID-19 antibody treatment to be distributed in the US. Continue Reading
-
News
10 Nov 2020
Eli Lilly’s COVID-19 Antibody Treatment Approved for Emergency Use
The authorization allows healthcare providers to administer a single-dose of the COVID-19 antibody treatment, in infected patients 12 years of age or older depending on weight. Continue Reading
-
News
05 Nov 2020
US Spending on Specialty Drugs Increases Year Over Year
Spending on specialty drugs has increased significantly in the US year over year for the three largest payers for drugs: Medicare Part D, Medicaid, and private insurance. Continue Reading
-
News
04 Nov 2020
Sanofi Inks $359M Pharma Acquisition Deal to Boost Cell Therapy
The pharma acquisition deal with Kiadis gives Sanofi access to the company’s cell-based platform to develop treatments for life-threatening diseases. Continue Reading
-
News
30 Oct 2020
Eli Lilly Strikes Deal with Govt Over COVID-19 Antibody Drug
HHS and DoD will purchase the first doses of the COVID-19 antibody drug as part of Operation Warp Speed’s goal to deliver coronavirus treatments to patients by the end of 2020. Continue Reading
-
News
26 Oct 2020
Roche, Atea Pharmaceuticals to Develop Oral COVID-19 Antiviral
The companies will jointly develop Atea’s COVID-19 antiviral, which has the potential to be the first novel oral drug to treat coronavirus patients in and out of the hospital. Continue Reading
-
News
23 Oct 2020
FDA Approves Remdesivir as the First COVID-19 Treatment
The FDA approval paves the way for widespread use of remdesivir as a COVID-19 treatment in hospitals and other healthcare settings. Continue Reading
-
News
14 Oct 2020
HHS, DoD to Scale-Up Manufacturing of COVID-19 Antibody Cocktail
The agreement will help to develop and manufacture AstraZeneca’s monoclonal COVID-19 antibody cocktail, which will treat or prevent infection with SARS-CoV-2. Continue Reading
-
News
14 Oct 2020
Eli Lilly Announces Supply Deal for COVID-19 Antibody Therapies
The supply deal will help to reduce the impact of the coronavirus for individuals in low- and middle-income countries by making COVID-19 antibody therapies more accessible. Continue Reading
-
News
12 Oct 2020
Insulin Prices 8x Higher in the US Compared to Similar Nations
In 2018, the average insulin prices in the US was $98.70, compared to $6.94 in Australia, $12.00 in Canada, and $7.52 in the UK. Continue Reading
-
News
07 Oct 2020
64% of New Drug Indications Lacked Pediatric Prescribing Info
The lack of pediatric prescribing information for new biologic and drug indications may be contributing to high rates of off-label and potentially unsafe use of drugs in children, researchers said. Continue Reading
-
News
06 Oct 2020
Major Pharma Companies Support Global Access to COVID-19 Vaccine
In collaboration with the Gates Foundation, top pharmaceutical companies made a commitment to expand global access to COVID-19 vaccines, diagnostics, and therapeutics. Continue Reading
-
News
30 Sep 2020
Eli Lilly, Amgen Partner to Advance COVID-19 Antibody Therapies
The collaboration will significantly increase global supply capacity for Lilly’s potential COVID-19 antibody therapies. Continue Reading
-
News
23 Sep 2020
GSK, Sanofi to Supply 300M Doses of COVID-19 Vaccine to EU
The agreement will allow for the purchase of a COVID-19 vaccine for all member states of the European Union, including lower- and middle-income countries. Continue Reading
-
News
18 Sep 2020
Bolstering the Pharmaceutical Supply Chain for a COVID-19 Vaccine
Creating specialized distribution channels, consumer-centric vaccination models, and advanced analytics will ensure a pharmaceutical supply chain that can turn COVID-19 vaccines into vaccinations. Continue Reading
-
News
17 Sep 2020
Prices of Brand Name Migraine Medications Continue to Increase
A recent GoodRx report found that brand name prevention and treatment migraine medications that don’t have generics can have hefty price tags for consumers. Continue Reading
-
News
17 Sep 2020
Brand Drug Product Hopping Costs US $4.7B Annually
Brand drug product hopping continues to burden the US healthcare system, underscoring the need for a federal solution, a new analysis says. Continue Reading
-
News
16 Sep 2020
Medicare Switches to Generic Cholesterol Drugs and Saves Billions
Between 2014 and 2018, the number of Medicare beneficiaries on cholesterol drugs went up, but total costs decreased, a recent study found. Continue Reading
-
News
10 Sep 2020
Mylan, Biocon Biologics Launch Diabetes Biosimilar in the US
After receiving FDA approval for the diabetes biosimilar back in June, Mylan will offer the biosimilar at the lowest wholesale acquisition cost for any long-acting insulin glargine on the market. Continue Reading
-
News
04 Sep 2020
NIH Challenges Use of Convalescent Plasma to Treat COVID-19
After FDA granted an emergency use authorization for convalescent plasma, NIH’s Panel found that the treatment is insufficient after reviewing data available from previous FDA analyses. Continue Reading
-
News
27 Aug 2020
Remdesivir May Not Greatly Help Moderately Ill COVID-19 Patients
The clinical benefits of using Gilead’s remdesivir as a treatment for moderately ill COVID-19 patients are uncertain despite evidence the drug works among severely ill patients. Continue Reading
-
News
26 Aug 2020
Mylan Launches First Generic to Tecfidera Despite Patent Debate
The recent FDA approval and launch of the generic drug follows Mylan’s win in the US District Court for the Northern District of West Virginia that invalidated Biogen's Tecfidera patent. Continue Reading
-
News
26 Aug 2020
Roche, Regeneron to Boost Supply of COVID-19 Antibody Combo
Roche and Regeneron will increase the supply of COVID-19 antibody, REGN-COV2, to at least three and a half times the current capacity, with potential for even further expansion. Continue Reading
-
News
24 Aug 2020
HHS Authorizes Pharmacists to Administer Childhood Vaccines
The move aims to expand access to childhood vaccines and decrease the risk of vaccine-preventable disease outbreaks as children prepare to return to daycare, preschool, and school. Continue Reading
-
News
20 Aug 2020
EU Launches Initiative to Accelerate COVID-19 Therapy Development
CARE will focus on drug repositioning, small-molecule drug discovery, and virus-neutralizing antibody discovery to accelerate COVID-19 therapy development. Continue Reading
-
News
19 Aug 2020
HHS, DoD Tap McKesson to Help with COVID-19 Vaccine Distribution
The collaboration is in support of the Trump Administration’s Operation Warp Speed, which accelerates the development, manufacturing, and distribution of COVID-19 vaccines. Continue Reading
-
News
18 Aug 2020
Drug Prices Increased over 25% for a Third of Products
The drug price increases generally affected lower-priced drugs, the dermatologic and oncology classes, and older drugs, a study found. Continue Reading
-
News
17 Aug 2020
AstraZeneca to Supply 400M Doses of COVID-19 Vaccine to EU
This is the first European Commission COVID-19 vaccine agreement that enables all EU member states to access the vaccine at no profit during the pandemic. Continue Reading
-
News
13 Aug 2020
HHS, DoD to Manufacture 100M Doses of Moderna’s COVID-19 Vaccine
The government will help manufacture the COVID-19 vaccine while clinical trials are underway to build towards Operation Warp Speed’s goal of delivering a safe and effective vaccine by the end of 2020. Continue Reading
-
News
11 Aug 2020
Pfizer to Manufacture Gilead’s Remdesivir for COVID-19 Treatment
The agreement between Pfizer and Gilead is just one of the multiple external manufacturing organizations supporting efforts to scale up supply of the COVID-19 treatment. Continue Reading
-
News
10 Aug 2020
Cost-Sharing for Privately Insured Increased for Brand Medicines
Commercial health plans are increasing using deductibles and coinsurance to shift the costs of brand medicines to patients, while new policies have made it harder for drug manufacturers to help. Continue Reading
-
News
04 Aug 2020
GSK, Sanofi to Supply 60M Doses of Its COVID-19 Vaccine to UK
The COVID-19 vaccine was developed using Sanofi’s protein-based technology, which was key to producing an influenza vaccine, and GSK’s pandemic adjuvant technology. Continue Reading
-
News
31 Jul 2020
Thermo Fisher Scientific to Up Manufacturing of Cell Therapies
The company will partner with biotech company Lyell Immunopharma to develop manufacturing processes to create more effective cell therapies for cancer patients. Continue Reading
-
News
23 Jul 2020
HHS Signs $1.95B Agreement to Produce Pfizer’s COVID-19 Vaccine
Under the terms of the agreement, the US government will acquire an additional 500 million doses of the COVID-19 vaccine and all Americans will receive the vaccine for free. Continue Reading
-
News
23 Jul 2020
GSK, CureVac Partner to Manufacture mRNA Vaccines, Antibodies
GSK and CureVac will leverage their individual mRNA technology platforms to develop and scale up mRNA vaccines and antibodies to treat and prevent infectious diseases like COVID-19. Continue Reading
-
News
16 Jul 2020
Microsoft Alliance Targets Real-Time Visibility for Supply Chains
Microsoft will use its cloud technologies and leverage C.H. Robinson’s Navisphere to make real-time visibility possible in supply chains and accelerate innovation in transportation. Continue Reading
-
News
15 Jul 2020
Roche to Co-Develop Investigational Therapy for RET-Altered Cancers
Roche will pay $675 million in cash upfront to Blueprint Medicines to co-commercialize investigational therapy, pralsetinib, intended for patients with RET-altered cancers. Continue Reading